within Pharmacolibrary.Drugs.ATC.C;

model C01CA25
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.5,
    Cl             = 60 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 10 / 1000000,
    adminCount     = 1,
    Vd             = 0.06,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0005,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Amezinium metilsulfate is a sympathomimetic amine that acts as both an indirect adrenergic agonist and a direct α-adrenergic agonist. It was used as a vasopressor to treat hypotension, primarily orthostatic hypotension. The drug is not widely approved or used today and is rarely found in current therapeutic guidelines.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters are not reported in accessible literature for any population, including healthy volunteers or patients. No clinical pharmacokinetic studies appear to exist or be indexed in major medical databases.</p><h4>References</h4><ol><li><p>Nambu, K, et al., &amp; Iwabuchi, M (1988). Disposition and metabolism of [14C]-amezinium metilsulfate in rats. <i>Arzneimittel-Forschung</i> 38(7) 909–918. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/3207436/&quot;>https://pubmed.ncbi.nlm.nih.gov/3207436</a></p></li><li><p>Traut, M, &amp; Brode, E (1981). Pharmacokinetics of amezinium in man. <i>Arzneimittel-Forschung</i> 31(9a) 1605–1615. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/7197975/&quot;>https://pubmed.ncbi.nlm.nih.gov/7197975</a></p></li><li><p>Brode, E, et al., &amp; Vollgraf, C (1983). The pharmacokinetics of ameziniummetilsulfate in man. Single and repetitive oral administration of a therapeutically effective dose. <i>Arzneimittel-Forschung</i> 33(10) 1491–1497. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/6686052/&quot;>https://pubmed.ncbi.nlm.nih.gov/6686052</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end C01CA25;
